Jeff Gerber
Forum Replies Created
-
With a name like Chikungunya I think they’ll have a hard time marketing that unless they come up with a shorter name. 🤞
-
To win at any game, you have to start playing, and I get the feeling we have an all-star team. Keep it up! 😉
-
If I’m not mistaken, he is talking about the ability to deploy and change genes in people. He is saying that this is of interest to DARPA as a way to respond to threats. What part of this is “informed consent”?
-
Here’s the full discourse:
“I’m Dan Wattendorf from the Defense Advanced Research Projects Agency. I’m in the biological technologies office and I thank you for inviting me here to speak to you here today. DARPA is particularly interested in this area because we feel like there are two aspects of this technology that are critically important to both deliberate on the capabilities and the security surrounding them. One is what is exceptional abo gene drives which is the ability for a genetic element particularly when it is synthetic or designed by an individual versus natural to propagate and change a population and the ability to do that could have security ramifications for the United States and the globe. Secondly, which is as Phil mentioned is the facility to perform these types of experiments and create these capabilities faster than whatever has been occurred before because the emergent technology of genome editing techniques.
Because of those two reasons, DARPA is looking at this technology as something that is capable for great benefit and is also potentially something that could be a security threat. Particularly at ecosystems and population levels for organisms that reproduce quickly such as agricultural or animal or plant. So, I think these circumstances are our key for us to be able to understand the deliberation of the community that is looking at the best way to inform the process of how to investigate these capabilities most effectively.
However, DARPA has a very specific role in the community to not admire the problem and be able to look at all the potential ramifications and even for both capability in good and in bad but also to be used as a tool to create technology that could either mitigate the threat or ensure that its success works in a safe way. So it is certainly within possibility that DARPA would take on efforts to invest in gene drive-based technologies in ways that would either provide it to be a safe tool or safe technology and ways that would be able to mitigate threats when used by our adversaries or by others who are malinformed or by doing it potentially with malfeasance in mind.
So, it is very helpful for us to not only understand the deliberations of this community, what you decide to do as you move forward, but also to be able to understand how you could point to what are technologies that you need to do to either make it safer or make it able for us to mitigate the threat.
So, we are particularly looking at not only the outcome of this group but potentially even specific recommendations to be able to understand where you see that those technologies being able to be helpful. Because we may be required to actually invest in technologies to improve this capability during the process of elaborating the challenges and benefits of it. Because we do not, we may not have the time in this case to actually wait for and make calls for certain scientific actions and communities to deliberate, we actually may need to be working on technology solutions right now; and the alacrity of our institution to be able to do that is that it can; and that’s where, why we are here today. To be able to follow that, thank you.”
Dan was the project manager for DARPA’s ADEPT mRNA pandemic solution; and here, he is talking about DARPA needing to weigh in on the new gene drive technology that these folks are congregating on. Clearly, DARPA sees this as a threat in the same way it sees a pandemic as a threat, and they want to get a handle on it and find solutions. In the manner he is speaking, to me it sounds like they already have ideas of what they want to do.
This is meddling with mother nature, God’s own design. “GMO” is being taken to a whole new level (species extinction can be a result) and the justifications of this collaboration, or the sales point, sounded like it is for the sake of solving malaria deaths in Africa. But the Colonel is pointing out it can also be for nefarious purposes and DARPA wants to be ready.
I don’t know if I’m more frightened by this group (NIH, FNIH, DARPA, and Gates Foundation) or by DARPA alone given the outcome and solutions used for the COVID pandemic. These scientists seem to feel entitled to play with mother nature and at the same time are admitting it is extremely dangerous.
The whole thing reminds me of a Jurassic Park movie on steroids…. toying with nature. “Gene drives can unintentionally spread beyond intended regions or species.”
The book The Coming Wave by Mustafa Suleyman addresses this topic of genetic engineering and I had to set the book down and stop reading it.
I hope I’ve called attention to this because I think the public needs to be able to weigh in on this. We already have GMO that somehow went without public opinion and oversight. Now this.
-
-
I had to do some digging as these names are not famliar to me. I think you’re referring to Otto’s Healing Revolution series, where Dr. Stillwagon discusses vaccine-related micro clotting and environmental toxins.
It’s very understandable to want to protect yourself from environmental toxins.
Fasting can be a powerful spiritual and physical reset, but if your body’s already weak or healing, deep fasting like you are suggesting might do more harm than good.
For a detox pure water, prayerful rest, fiber-rich foods, and gentle movement to support your lymph and liver can probably help. Chlorella and apple juice can probably help too. EDTA is a strong chelating medical agent, and it would be best to consult with a medical professional on that one.
I’m not a medical professional but if you are worried about vaccine micro clotting, you can look at the protocols here: https://imahealth.org/treatment-protocols/ .
-
As a bonus, I was curious to ask Copilot what might have a greater binding affinity to α7 than nicotine and therefore with might do a decent job of addressing PVS PEM. I have not found any studies that indicate either of the following drugs are being studied for use with PEM or PVS.
Drug Repurposing
Question to Copilot: The research surrounding – PNU-282987 and GTS-21, what phenotypes are being addressed?
Both PNU-282987 and GTS-21 are selective agonists of the α7 nicotinic acetylcholine receptor (α7 nAChR), and they’ve been studied across a range of phenotypes—from neurodegeneration to inflammation and immune modulation. Here’s a synthesis of the phenotypes and disease models where these compounds have shown promise:
Neurological and Cognitive Phenotypes
| Compound | Phenotype | Mechanism | Notes |
| PNU-282987 | Schizophrenia-like gating deficits | Enhances hippocampal GABAergic transmission and oscillatory activity | Improves auditory gating and cognitive function |
| GTS-21 | Alzheimer’s disease, Parkinson’s disease | Anti-inflammatory, neuroprotective, improves memory | Acts via α7 nAChR and downstream PI3K/Akt, Nrf2, CREB, PPARγ signaling |
| GTS-21 | Nicotine dependence | Partial agonism at α7, modulates reward circuitry | Investigated for addiction modulation |
Immunological and Inflammatory Phenotypes
| Compound | Phenotype | Mechanism | Notes |
| PNU-282987 | Allergic airway inflammation (e.g., asthma) | Suppresses ILC2 activation, reduces IL-33–induced inflammation | Reduces goblet cell hyperplasia, eosinophil infiltration |
| GTS-21 | Sepsis, endotoxemia | Inhibits TNF, IL-6 via NF-κB blockade | Effects partially independent of α7 nAChR in some cell types |
| GTS-21 | Rheumatoid arthritis | Reduces synovial inflammation and monocyte infiltration | Via cholinergic anti-inflammatory pathway |
Regenerative and Cellular Repair Phenotypes
| Compound | Phenotype | Mechanism | Notes |
| PNU-282987 | Retinal neurogenesis | Stimulates Müller glia to produce progenitor neurons | Activates retinal pigment epithelium signaling |
| GTS-21 | Atrial fibrillation in sepsis | Modulates macrophage activity | Reduces arrhythmia incidence in septic mice |
Summary
Both compounds target α7 nAChRs, but:
– PNU-282987 is more selective and potent, often used in mechanistic studies.
– GTS-21 is a partial agonist with broader systemic effects and has been tested in more clinical contexts.
These agents are being explored for:
– Neurodegenerative diseases
– Psychiatric disorders
– Autoimmune and inflammatory conditions
– Tissue regeneration and repair
-
Other than glyphosate, another one that I have found disturbing for years is Malathion. I remember seeing what looked like clear honey droplets stuck to the windshield of my car in Florida. Someone explained to me that was a pesticide and that when it breaks down in sunlight it creates a carcinogen.
-
Here we go. Yes, the breakdown of Melathion to Malaoxon (which has been know at least since the 1990’s as the toxin) is still poised to pose health risks to humans.
https://www.epa.gov/pesticides/epa-releases-updated-draft-risk-assessment-pesticide-malathion
“The human health risk assessment for malathion includes an assessment of malaoxon, its breakdown product that is formed through metabolism and degradation. Malaoxon is the active form of malathion that is responsible for interacting with the nervous system through inhibition of the acetylcholinesterase (AChE) enzyme. This process is what makes the pesticide effective against insects, but the process can also occur in mammals, including humans, depending on the level of malathion exposure. AChE inhibition has been found to be the most sensitive effect for malathion, and EPA has a long-standing history of using a 10% change in AChE levels as the basis for its organophosphate human health risk assessments.”
epa.gov
EPA Releases Updated Draft Risk Assessment for Pesticide Malathion | US EPA
Environmental Protection Agency released an updated draft human health risk assessment (HH DRA) for the pesticide malathion
-
-
The photo from today appears pixelated. I’ll try to add it again here:
-
I asked copilot about the complexity of the M protein versus the Spike protein (see attached image). From this you get something of the genius of what Dr. Soon did. You see, with T cells he had a choice of what to train them to learn about SARS-2 and he decided on teaching them about the M protein rather than the Spike protein.
Why?
If you use antibodies as your methodology (as they did with mRNA) then the antibodies need to react to the protein. M protein antibodies don’t react much to… M protein is not “immunogenic” and so you won’t produce much for antibodies.
So why train killer T cells on M protein rather than spike? You see, the mRNA approach that RFK Jr. mentioned in his latest speech doesn’t work because the Spike protein will change – “High mutation rate” because it is a complex protein. Meanwhile, the M protein is simpler and “relatively conserved across variants”. So, the moment the Omicron variant came out, the mRNA vaccines were already outdated and didn’t work to produce antibodies for Omicron. But the M protein stayed the same and that means any approach that could identify the pathogen consistently across variants would have continued to kill the pathogen.
But the underlying theme here is that the mRNA NEVER worked because it didn’t come out until after the mutations to Spike protein started happening. It is a COMPLETE failure as a strategy.
-
❤
I absolutely love this and everything Secretary Kennedy is doing. He keeps putting a smile on my face over and over again.
I’ve posted before about it, but I am in firm agreement with the narrative Dr. Peter McCullough presented. Our government, our military, funded a research project called ADEPT starting in 2012 through DARPA (the same folks that created the internet, formerly known as DARPANet). The ADEPT project was focused on developing a way to quickly deploy a vaccine and stop a pandemic, initially meant to deploy to our troops. The idea was mRNA. So, when a real pandemic hit, our government looked to them as the experts and let something that was still theoretical and never tried before, become the solution for American citizens and the world. They were given the green light. Now it’s time to reevaluate that decision, acknowledge practice didn’t match theory, and accept failure. You can watch youtube videos of Air Force Colonel Daniel J. Wattendorf presenting the early rumblings of ADEPT. Well meaning, but a failed experiment. Let’s end this.
-
The brainwashing is so bad that I think even if I could get folks to watch In the Shadow of Flexner, point at it and say, “this is why you think the way you do”, they still wouldn’t believe it. https://youtu.be/FuRB0mNLPhM
☹
-
Here’s a progression of treating tinea versicolor on my wife using RLT+MB (2% solution). Initial state is shown under Wood’s lamp. What’s fascinating about the methylene blue is it won’t stain healthy skin cells. So, it is a great way of identifying unhealthy skin as well. The interval was 2 months of progress.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9233483/
pmc.ncbi.nlm.nih.gov
Photodynamic Therapy for the Treatment of Fungal Infections - PMC
Cutaneous fungal infections are common in humans and are associated with significant physical and psychological distress to patients. Although conventional topical and/or oral anti-fungal medications are commonly recommended treatments, drug ...
-
I should add that the trick with methylene blue didn’t occur to me to try until after my wife used RLT+MB it to treat her tinea versicolor. We used a Woods lamp to look at the tinea and took before and after pictures.
I figured it couldn’t hurt to try it for myself, and I took a chance with the undiagnosed patch on my temple that had been there over a year. I was already seeing so many doctors for other issues that going to a dermatologist would have been too much. So, I gave it a try and was absolutely amazed how well it worked for something I have no idea what the diagnosis would have been. All I know is it was discolored and itchy.
-
I invested in a standing panel and started using the red-light therapy as a result of Dr. Marik’s 2023 FLCCC presentation and my need to find solutions to my severe health issues with post vaccine syndrome.
What I like about red light therapy is it penetrates below the skin (5 cm with near infrared), and it fixes damaged cells. I’d like to say “I can feel it working” but that is pretty subjective. More objective, that I already shared, is that with methylene blue I was able to completely solve a skin issue in only 4 20-minute sessions. That’s saying something measurable and significant about the effects.
At first, I couldn’t tolerate more than 5 minutes. I was very sensitive to temperature and feeling exhausted, which is/was part of my condition. I’d basically feel like I would pass out if I stood there any longer. Now I can tolerate the full 20 minutes without a problem and the heat simply feels good. I also think it helps with sleep. I was always short on quality sleep and I’ve done a number of things to help me sleep, but it’s probably the natural production of melatonin from the red light that has a lot to do with that.
So, yes, sleep and energy definitely have been improved. Fixing my skin and getting rid of wrinkles was not the goal, more of a fringe benefit; but it’s something I can share, and it shows what is happening on the outside. I can only imagine the good things it is doing on the inside based on what I see on the outside.
I have autoimmune thyroid. A great thing about the light and thyroid is the light doesn’t have to penetrate too far to get to the thyroid. Last year, Feb 2024, I had thyroglobulin antibodies >2250.0 (above the max the test reads) as well as ultrasound reporting “1.5 x 3.5 x 1.2 cm complex cystic and solid left upper thyroid nodule”. Recently, my problem swallowing has gotten better, and I suspect next time I have an ultrasound I will see an improvement in the thyroid. Granted I’m doing a lot of things for my health, but the red light is most likely supporting many things in my body at once.